Kalocyte

About:

Kalocyte provides red blood cell substitutes used for trauma care related services.

Website: http://kalocyte.com/wordpress/

Top Investors: BioGenerator, Small Business Innovation Research, NYBC Ventures, Skandalaris Center for Interdisciplinary Innovation and Entrepreneurship, Comcast RISE

Description:

Kalocyte is a pre-clinical stage healthcare biotech startup company that provides artificial red blood cell substitutes used for trauma care related services. The company develops a demonstrated proof of concept for ErythroMer, a dried, bio-inspired artificial red blood cell envisioned for use when stored red blood cells are unavailable, undesirable, or in short supply. Kalocyte was founded in 2016 and is headquartered in Baltimore, Maryland.